Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced that Cosmo Bio will distribute its products in Japan.

Under the deal, Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear. The system comprises a complete reporter assay solution that includes a genome-wide collection of human promoter and 3' UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.